2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$31.15+$2.54 (+8.88%)
Price as of Nov 11, 2026 7:44 PM EST- $1.1BMarket Cap
- 113.51%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$31.15+$2.54 (+8.88%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.61 | ||
Change | +$0.81 (+2.91%) | ||
Open | $27.55 | ||
High | $28.84 | ||
Low | $27.05 | ||
Previous Close | $27.80 | ||
Volume | 515,840 | ||
30-Day Average Volume | 618,527 | ||
1-Week Change | 26.04% | ||
1-Month Change | 17.40% | ||
1-Year Change | 113.51% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 39.2M | ||
Total Assets | $326.5M | ||
Market Cap | $1.1B | ||
Enterprise Value | $819.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$25.1M | ||
Free Cash Flow | -$20.8M | ||
EBIT | -$24.6M | ||
EBITDA | -$24.4M | ||
Net Working Capital | $305.4M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -53 | ||
PEG | -3 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue